Predictmedix (PMEDF)
OTHER OTC:PMEDF

Predictmedix (PMEDF) Stock Price & Analysis

7 Followers

PMEDF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.10
Previous Close$0.01
Volume506.00
Average Volume (3M)40.26K
Market Cap
$1.09M
Enterprise Value$1.07M
Total Cash (Recent Filing)C$36.87K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)
Beta-0.44
Sep 27, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding150,259,542
10 Day Avg. Volume7,341
30 Day Avg. Volume40,260
Standard Deviation0.45
R-Squared0.09
Alpha0.00682
Financial Highlights & Ratios
Price to Book (P/B)-9.13
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

22.35%0.00%0.00%77.65%
22.35% Insiders
0.00% Other Institutional Investors
77.65% Public Companies and
Individual Investors

PMEDF FAQ

What was Predictmedix’s price range in the past 12 months?
Predictmedix lowest stock price was <$0.01 and its highest was $0.10 in the past 12 months.
    What is Predictmedix’s market cap?
    Currently, no data Available
    When is Predictmedix’s upcoming earnings report date?
    Predictmedix’s upcoming earnings report date is Sep 27, 2024 which is in 65 days.
      How were Predictmedix’s earnings last quarter?
      Predictmedix released its earnings results on Jul 02, 2024. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
        Is Predictmedix overvalued?
        According to Wall Street analysts Predictmedix’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Predictmedix pay dividends?
          Predictmedix does not currently pay dividends.
          What is Predictmedix’s EPS estimate?
          Predictmedix’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Predictmedix have?
          Predictmedix has 150,259,540 shares outstanding.
            What happened to Predictmedix’s price movement after its last earnings report?
            Predictmedix reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Predictmedix?
              Currently, no hedge funds are holding shares in PMEDF
              ---

              Predictmedix Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -86.41%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              -30.90%
              Trailing 12-Months

              Company Description

              Predictmedix

              Predictmedix Inc is engaged in the development of medical devices. It is into the development of cannabis-derived products with clinical efficacy to artificial intelligence-based solutions to detect cannabis impairment. Its products use facial, thermal, video and audio recognition technologies to determine when individuals are impaired, suffering from infectious disease or mental illness.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Novavax
              BioCryst
              Inovio Pharmaceuticals
              Vericel
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis